Key result
Female sex is linked to ~29% greater absolute 5-year survival in thoracic angiosarcoma versus males.
Why the study?
Thoracic angiosarcoma is a very rare and malignant disease, prompting an examination of its incidence and survival with a special focus on primary and secondary angiosarcomas.
Observational (n=421)
Yes
Thoracic angiosarcoma is a rare malignancy with a poor prognosis, where topography is the main prognostic factor and women exhibit better survival than men regardless of primary or secondary tumor status.
Answers are grounded in this paper and cite their sources.
Female survival advantage in thoracic angiosarcoma may refine prognosis; leaves open validation and mechanistic inquiry in prospective cohorts.
Introduction: Thoracic angiosarcoma is a very rare and malignant disease. This study examined the incidence and survival of thoracic angiosarcomas with special focus on primary and secondary angiosarcomas. Methods: Data from the population-based North Rhine-Westphalia (NRW) cancer registry in Germany covering the years 2008–2023 were analyzed, including primary and secondary thoracic angiosarcoma (ICD-O-3: morphology 9120/3, topography C34, C38, C44.51, C49.3, C50), and reported age-standardized incidence rates (using the Old European Standard population) and survival analyses (Kaplan–Meier curves). Results: A total of 421 cases of thoracic angiosarcoma were analyzed, and 90.0% of the patients were female (n = 379). Age-standardized incidence rates of thoracic angiosarcoma were 0.25 per million per year for male patients (SE 0.0) and 1.5 per million per year for female patients (SE 0.1). All male patients had primary angiosarcoma (n = 42). Among female patients, the majority of cases were second primary tumors (n = 262, 69.1%). The 5-year overall survival (OS) for the cohort study was 38.5% (SE 2.6). Stratified by sex, OS was 41.1% (SE 2.8) for women and 12.0% (SE 5.4) for men. Among female patients, OS was 40.9% (SE 4.1) for primary and 41.8% (SE 3.8) for second primary angiosarcoma. The worst OS occurred among patients with angiosarcoma of the lung (men 20.0% (SE 12.7)) and of the mediastinum, heart and pleura (men 4.7% (SE 4.5)) The OS for women was 0%; all females died within 2.2 years after diagnosis of angiosarcoma with these topographies. Conclusions: Thoracic angiosarcoma is a rare condition with a poor prognosis. Irrespective of whether their disease is classified as primary or second primary, women with angiosarcoma have a better prognosis than men. Topography seems to be the most determining prognostic factor in this disease.
No takes yet. Share an insight, caveat, or question.
Dörr-Jerat et al. (2026) conducted an observational in Patients diagnosed with thoracic angiosarcoma in North Rhine-Westphalia, Germany (n=421). Female patients with thoracic angiosarcoma had a 5-year overall survival of 41.4% compared to 12.0% in male patients, with topography impacting prognosis most significantly.
Synapse has enriched 10 related papers. Consider them for comparative context: